0001209191-18-013734.txt : 20180227
0001209191-18-013734.hdr.sgml : 20180227
20180227103249
ACCESSION NUMBER: 0001209191-18-013734
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180222
FILED AS OF DATE: 20180227
DATE AS OF CHANGE: 20180227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Montesino Ibelis
CENTRAL INDEX KEY: 0001513887
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32381
FILM NUMBER: 18643388
MAIL ADDRESS:
STREET 1: 800 W. OLYMPIC BLVD., SUITE 406
CITY: LOS ANGELES
STATE: X1
ZIP: 90015
FORMER NAME:
FORMER CONFORMED NAME: Fleming Ibelis
DATE OF NAME CHANGE: 20110224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERBALIFE LTD.
CENTRAL INDEX KEY: 0001180262
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 309GT
STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: 00000
BUSINESS PHONE: 310 410 9600
MAIL ADDRESS:
STREET 1: P.O. BOX 309GT
STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: WH HOLDINGS CAYMAN ISLANDS LTD
DATE OF NAME CHANGE: 20020814
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-22
0
0001180262
HERBALIFE LTD.
HLF
0001513887
Montesino Ibelis
800 W. OLYMPIC BLVD., SUITE 406
LOS ANGELES
CA
90015
0
1
0
0
SVP/Managing Dir North America
Common Stock
2018-02-26
4
A
0
4634
0.00
A
4634
D
Stock Appreciation Rights
30.44
2018-02-22
4
A
0
19576
0.00
A
2018-03-02
2025-03-02
Common Stock
19576
19576
D
Stock Appreciation Rights
47.80
2018-02-22
4
A
0
7500
0.00
A
2018-05-07
2025-05-07
Common Stock
7500
12500
D
Stock Appreciation Rights
62.51
2018-02-22
4
A
0
2687
0.00
A
2018-05-09
2026-05-09
Common Stock
2687
5375
D
Stock Appreciation Rights
57.19
2018-02-22
4
A
0
2825
0.00
A
2018-02-27
2027-02-27
Common Stock
2825
2825
D
Consists of restricted stock units ("RSU") under the Herbalife Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Ltd. common stock on vesting. This award will vest 20% each on February 26, 2019 and February 26, 2020, and 60% on February 26, 2021.
On March 2, 2015, the reporting person was granted an award of 32,626 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 19,576 SARs which will vest on March 2, 2018.
On May 7, 2015, the reporting person was granted an award of 12,500 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 7,500 SARs which will vest on May 7, 2018.
On May 9, 2016, the reporting person was granted an award of 13,436 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 2,687 SARs which will vest on May 9, 2018.
On February 27, 2017, the reporting person was granted an award of 14,124 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2017, 2018 and 2019. The performance criteria for 2017 was met, resulting in 2,825 SARs which will vest on February 27, 2018.
/s/ Eileen Uy, Attorney-in-Fact for Ibelis Montesino
2018-02-27